Acrostak

medical devices

About

Acrostak is a Swiss medical device company founded in 2001, specializing in innovative products for interventional cardiology. The company focuses on treating chronic total occlusion (CTO) lesions and aims to lead the interventional applications market by enhancing patient outcomes with high-quality devices. Acrostak offers a variety of specialized medical devices, including CTO balloons designed to navigate challenging lesions, PTCA balloons for coronary angioplasty, and microcatheters for complex vascular pathways. The company collaborates with leading hospitals and cardiologists worldwide to ensure its products meet clinical needs. With a commitment to innovation and effective communication, Acrostak operates under the name Acrostak (Schweiz) AG in Winterthur, Switzerland, and has a presence in the UK through ACROSTAK-UK LIMITED.

Technologies

Cloudflare DNSMailchimp MandrillOutlookMicrosoft Office 365CloudFlare HostingGoogle AnalyticsMobile FriendlyGoogle Font API

Keywords

medical equipment manufacturingcalcified lesionsspecialty balloonshigh burst pressuredistal lesion accessrapid exchangemedical technologypuncture resistant balloonbiomedical engineeringmicrocathetersb2bpolyamide balloon materialguiding catheterssemi-compliant balloonptca balloonschronic total occlusioncardiologydebulking balloonpercutaneous coronary interventioninterventional cardiologycto balloondistal lesion crossing deviceballoon dilationhigh pushability balloonspecialty balloonptca balloonhealthcare equipment & suppliesinterventional technologyguidewire compatibilitylesion crossing

Location

14 Stegackerstrasse, Winterthur, Zurich, Switzerland, 8409

Related Companies

Companies in the same industry